Table 4. Clinical practice guidelines for the pharmacological treatment of depression: Subtypes of depression.

Recommendations/clinical practice guidelines	Chilean CPG1 [21]	Colombian CPG [22]	England CPG [23]	ICSI2 CPG [24]	APA3 CPG [26]	CANMAT4 CPG [25]
Subtypes of depression	-	●	●	●	●	●
Chronic or dysthymia	-	-	-	●	-	-
Combination of antidepressants and psychotherapy	-	-	-	●	-	-
Beginning of pharmacological treatment (pure dysthymia)	-	-	-	●	-	-
Depression with psychotic features	-	●	●	-	●	●
Contraindication of isolated psychotherapy	-	-	-	-	-	-
Indication of antipsychotic agents in combination with antidepressants	-	●	●	-	●	●
Catatonic	-	-	-	-	●	●
Benzodiazepines in combination with antidepressants	-	-	-	-	●	●
Barbiturates in combination with antidepressants	-	-	-	-	●	-
Depression with atypical features	-	-	-	●	●	●
Monoamine oxidase inhibitors	-	-	-	●	●	-
Selective serotonin reuptake inhibitors and bupropion	-	-	-	-	●	-
No specific antidepressants have demonstrated superiority	-	-	-	-	-	●
Depression with melancholic features	-	-	-	-	●	●
Serotonin and noradrenaline reuptake inhibitors and tricyclic antidepressants	-	-	-	-	●	-
No specific antidepressants have demonstrated superiority	-	-	-	-	-	●
Depression with seasonal pattern	-	-	-	-	-	●
No specific antidepressants have demonstrated superiority	-	-	-	-	-	●
Depression with somatic symptoms (fatigue)	-	-	-	-	-	●
Mixed depression disorder	-	-	-	-	-	●

¹CPG = clinical practice guideline;

²ICSI = Institute for Clinical Systems Improvement;

³APA = American Psychiatry Association;

⁴CANMAT = Canadian Network for Mood and Anxiety Treatments.

● = CPG does contain topic; - = CPG does not contain topic.